Article info

Download PDFPDF
Original research
Globotriaosylsphingosine (lyso-Gb3) and analogues in plasma and urine of patients with Fabry disease and correlations with long-term treatment and genotypes in a nationwide female Danish cohort

Authors

  1. Correspondence to Dr Christiane Auray-Blais, Pediatrics, Université de Sherbrooke, Sherbrooke, QC J1H 5N4, Canada; christiane.auray-blais{at}usherbrooke.ca
View Full Text

Citation

Effraimidis G, Feldt-Rasmussen U, Rasmussen ÅK, et al
Globotriaosylsphingosine (lyso-Gb3) and analogues in plasma and urine of patients with Fabry disease and correlations with long-term treatment and genotypes in a nationwide female Danish cohort

Publication history

  • Received May 4, 2020
  • Revised July 14, 2020
  • Accepted August 3, 2020
  • First published September 22, 2020.
Online issue publication 
September 22, 2021

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.